// App-Quantinova.ai

3060 : Development of New Autoimmunity Against T Cell Antigens Derived From Retinal Proteins After Allogeneic Hematopoietic Cell Transplantation.

Researchers

Presenter

  • Christoph Faul

Principal Investigators

  • Christiane Dorn

  • Wichard Vogel

  • Wolfgang A. Bethge

  • Lothar Kanz

  • Hans-Georg Rammensee

  • Sebastian P. Haen

Medical Centers

  • Abteilung fur Hamatologie, Onkologie, Immunologie, Rheumatologie und Pulmologie, Medizinische Universitatsklinik Tubingen, Tuebingen, Germany

  • Department of Neurosurgery, Eberhard Karls University, Tubingen, Germany

  • Department of Hematology, Oncology, Immunology, Rheumatology and Pulmonology, University Hospital of Tuebingen, Tuebingen, Germany

  • Abteilung fur Hamatologie, Onkologie, Immunologie, Rheumatologie und Pulmologie, Medizinische Universitatsklinik Tubingen, Tuebingen, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Acute lymphoblastic leukemia

  • B-Cell Non-Hodgkin Lymphoma

  • Peripheral T-cell lymphoma

  • Graft-versus-host disease

  • Alpha-thalassemia myelodysplasia syndrome

  • Chronic Myelogenous Leukemia

  • Immune thrombocytopenia

  • Acute myelocytic leukemia

  • Non-Hodgkin's Lymphoma

  • Non‐Hodgkin Lymphoma

  • Follicular lymphoma

  • Hodgkin's Lymphoma

  • Myasthenia gravis

  • Polycythemia vera

  • Thrombocytopenia

  • T-cell lymphoma

  • Myelofibrosis

  • Lymphomas

  • Anemia

  • Autoimmune hemolytic anemia

Biomarkers

  • Peripheral blood mononuclear cell

  • Cluster of Differentiation 4

  • E2F transcription factor 1

  • Hematocrit

Drug/Treatment

  • Tigason

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved